BCLI logo

BCLI Retained Earnings

Annual Retained Earnings

-$215.01 M
-$17.19 M-8.69%

December 31, 2023


Summary


Performance

BCLI Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBCLIbalance sheetmetrics:

Quarterly Retained Earnings

-$223.66 M
-$2.71 M-1.23%

September 30, 2024


Summary


Performance

BCLI Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBCLIbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

BCLI Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8.7%-1.2%
3 y3 years-44.2%-1.2%
5 y5 years-128.7%-1.2%

BCLI Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-23.9%at low-28.9%at low
5 y5-year-83.3%at low-90.7%at low
alltimeall time<-9999.0%at low<-9999.0%at low

Brainstorm Cell Therapeutics Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$223.66 M(+1.2%)
Jun 2024
-
-$220.96 M(+1.2%)
Mar 2024
-
-$218.41 M(+1.6%)
Dec 2023
-$215.01 M(+8.7%)
-$215.01 M(+2.7%)
Sep 2023
-
-$209.44 M(+0.6%)
Jun 2023
-
-$208.21 M(+2.6%)
Mar 2023
-
-$202.88 M(+2.6%)
Dec 2022
-$197.82 M(+14.0%)
-$197.82 M(+2.6%)
Sep 2022
-
-$192.80 M(+3.7%)
Jun 2022
-
-$185.94 M(+3.9%)
Mar 2022
-
-$178.90 M(+3.1%)
Dec 2021
-$173.54 M(+16.4%)
-$173.54 M(+3.7%)
Sep 2021
-
-$167.35 M(+3.3%)
Jun 2021
-
-$162.02 M(+4.0%)
Mar 2021
-
-$155.75 M(+4.5%)
Dec 2020
-$149.09 M(+27.1%)
-$149.09 M(+8.6%)
Sep 2020
-
-$137.27 M(+3.4%)
Jun 2020
-
-$132.78 M(+5.9%)
Mar 2020
-
-$125.39 M(+6.9%)
Dec 2019
-$117.28 M(+24.7%)
-$117.28 M(+7.0%)
Sep 2019
-
-$109.58 M(+5.4%)
Jun 2019
-
-$103.95 M(+4.9%)
Mar 2019
-
-$99.05 M(+5.3%)
Dec 2018
-$94.02 M(+17.4%)
-$94.02 M(+6.1%)
Sep 2018
-
-$88.64 M(+3.7%)
Jun 2018
-
-$85.46 M(+3.8%)
Mar 2018
-
-$82.37 M(+2.9%)
Dec 2017
-$80.08 M(+6.6%)
-$80.08 M(-0.3%)
Sep 2017
-
-$80.35 M(+3.1%)
Jun 2017
-
-$77.95 M(+1.4%)
Mar 2017
-
-$76.91 M(+2.4%)
Dec 2016
-$75.12 M(+7.1%)
-$75.12 M(+0.8%)
Sep 2016
-
-$74.50 M(+2.2%)
Jun 2016
-
-$72.89 M(+1.3%)
Mar 2016
-
-$71.93 M(+2.6%)
Dec 2015
-$70.14 M(+13.8%)
-$70.14 M(+2.0%)
Sep 2015
-
-$68.76 M(+3.9%)
Jun 2015
-
-$66.15 M(+3.5%)
Mar 2015
-
-$63.89 M(+3.6%)
Dec 2014
-$61.65 M(+17.6%)
-$61.65 M(+4.6%)
Sep 2014
-
-$58.92 M(+4.3%)
Jun 2014
-
-$56.50 M(+3.6%)
Mar 2014
-
-$54.52 M(+4.0%)
Dec 2013
-$52.41 M
-$52.41 M(+2.4%)
Sep 2013
-
-$51.19 M(+2.2%)
Jun 2013
-
-$50.11 M(+3.1%)
DateAnnualQuarterly
Mar 2013
-
-$48.59 M(+2.3%)
Dec 2012
-$47.51 M(+7.8%)
-$47.51 M(+1.2%)
Sep 2012
-
-$46.93 M(+2.5%)
Jun 2012
-
-$45.78 M(+1.8%)
Mar 2012
-
-$44.95 M(+2.0%)
Dec 2011
-$44.08 M(+9.8%)
-$44.08 M(+3.3%)
Sep 2011
-
-$42.66 M(+1.7%)
Jun 2011
-
-$41.96 M(+2.7%)
Mar 2011
-
-$40.87 M(+1.8%)
Dec 2010
-$40.16 M(+6.4%)
-$40.16 M(+1.2%)
Sep 2010
-
-$39.67 M(+1.8%)
Jun 2010
-
-$38.97 M(+1.6%)
Mar 2010
-
-$38.36 M(+1.6%)
Dec 2009
-$37.74 M(+5.0%)
-$37.74 M(+0.3%)
Sep 2009
-
-$37.64 M(+1.7%)
Jun 2009
-
-$37.02 M(+1.5%)
Mar 2009
-
-$36.47 M(+1.4%)
Dec 2008
-$35.96 M(+10.7%)
-$35.96 M(+1.8%)
Sep 2008
-
-$35.33 M(+2.1%)
Jun 2008
-
-$34.61 M(+2.5%)
Mar 2008
-
-$33.75 M(+3.9%)
Dec 2007
-$32.49 M(+23.8%)
-$32.49 M(+6.2%)
Sep 2007
-
-$30.58 M(+5.0%)
Jun 2007
-
-$29.12 M(+4.1%)
Mar 2007
-
-$27.97 M(+15.5%)
Dec 2006
-$26.24 M(+17.6%)
-
Sep 2006
-
-$24.22 M(+4.5%)
Jun 2006
-
-$23.17 M(+3.8%)
Mar 2006
-
-$22.32 M(+2.8%)
Mar 2006
-$22.32 M(+17.5%)
-
Dec 2005
-
-$21.70 M(+4.4%)
Sep 2005
-
-$20.78 M(+5.3%)
Jun 2005
-
-$19.74 M(+3.9%)
Mar 2005
-$19.00 M(>+9900.0%)
-$19.00 M(+3.1%)
Dec 2004
-
-$18.44 M(+960.4%)
Sep 2004
-
-$1.74 M(+1126.3%)
Jun 2004
-
-$141.80 K(-12.8%)
Mar 2004
-$162.70 K(+82.0%)
-$162.70 K(+28.2%)
Dec 2003
-
-$126.90 K(+13.0%)
Sep 2003
-
-$112.30 K(+10.9%)
Jun 2003
-
-$101.30 K(+13.3%)
Mar 2003
-$89.40 K(+109.9%)
-$89.40 K(+22.6%)
Dec 2002
-
-$72.90 K(+22.7%)
Sep 2002
-
-$59.40 K(+16.0%)
Jun 2002
-
-$51.20 K
Mar 2002
-$42.60 K
-

FAQ

  • What is Brainstorm Cell Therapeutics annual retained earnings?
  • What is the all time high annual retained earnings for Brainstorm Cell Therapeutics?
  • What is Brainstorm Cell Therapeutics annual retained earnings year-on-year change?
  • What is Brainstorm Cell Therapeutics quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Brainstorm Cell Therapeutics?
  • What is Brainstorm Cell Therapeutics quarterly retained earnings year-on-year change?

What is Brainstorm Cell Therapeutics annual retained earnings?

The current annual retained earnings of BCLI is -$215.01 M

What is the all time high annual retained earnings for Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics all-time high annual retained earnings is -$42.60 K

What is Brainstorm Cell Therapeutics annual retained earnings year-on-year change?

Over the past year, BCLI annual retained earnings has changed by -$17.19 M (-8.69%)

What is Brainstorm Cell Therapeutics quarterly retained earnings?

The current quarterly retained earnings of BCLI is -$223.66 M

What is the all time high quarterly retained earnings for Brainstorm Cell Therapeutics?

Brainstorm Cell Therapeutics all-time high quarterly retained earnings is -$51.20 K

What is Brainstorm Cell Therapeutics quarterly retained earnings year-on-year change?

Over the past year, BCLI quarterly retained earnings has changed by -$2.71 M (-1.23%)